Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$41.99 - $62.38 $122,190 - $181,525
-2,910 Reduced 90.94%
290 $17,000
Q3 2023

Nov 13, 2023

BUY
$27.8 - $45.35 $37,891 - $61,812
1,363 Added 74.2%
3,200 $139,000
Q2 2023

Aug 10, 2023

SELL
$36.13 - $49.49 $2,456 - $3,365
-68 Reduced 3.57%
1,837 $66,000
Q1 2023

May 12, 2023

SELL
$36.54 - $54.26 $12,240 - $18,177
-335 Reduced 14.96%
1,905 $70,000
Q4 2022

Feb 10, 2023

BUY
$41.27 - $98.62 $29,755 - $71,105
721 Added 47.47%
2,240 $101,000
Q3 2022

Nov 14, 2022

BUY
$59.5 - $86.7 $2,558 - $3,728
43 Added 2.91%
1,519 $105,000
Q2 2022

Aug 10, 2022

BUY
$39.16 - $88.71 $32,581 - $73,806
832 Added 129.19%
1,476 $99,000
Q1 2022

May 04, 2022

BUY
$75.82 - $150.97 $11,827 - $23,551
156 Added 31.97%
644 $52,000
Q3 2021

Nov 05, 2021

BUY
$132.13 - $177.45 $23,519 - $31,586
178 Added 57.42%
488 $87,000
Q2 2021

Aug 02, 2021

SELL
$144.0 - $179.73 $5,472 - $6,829
-38 Reduced 10.92%
310 $50,000
Q1 2021

May 13, 2021

BUY
$158.92 - $221.61 $2,065 - $2,880
13 Added 3.88%
348 $59,000
Q4 2020

Feb 10, 2021

SELL
$162.05 - $240.27 $19,283 - $28,592
-119 Reduced 26.21%
335 $73,000
Q3 2020

Nov 12, 2020

BUY
$113.26 - $167.27 $12,232 - $18,065
108 Added 31.21%
454 $76,000
Q2 2020

Aug 14, 2020

SELL
$72.01 - $120.39 $1.47 Million - $2.45 Million
-20,380 Reduced 98.33%
346 $39,000
Q1 2020

May 18, 2020

BUY
$69.78 - $116.21 $1.45 Million - $2.41 Million
20,726 New
20,726 $28,000

Others Institutions Holding MRTX

About Mirati Therapeutics, Inc.


  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.